NDC 62993-0002 – Docusate Sodium and Sennosides
Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Tablet · Oral
Product NDC62993-0002
Product details
- Brand name
- Docusate Sodium and Sennosides
- Generic name
- Docusate Sodium and Sennosides
- Labeler
- Morepen Laboratories Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M007
- Marketed since
- October 1, 2025
- Listing expires
- December 31, 2027
Active ingredients
- Docusate Sodium 50 mg/1
- Sennosides 8.6 mg/1
Uses, dosage, side effects and warnings for Docusate Sodium and Sennosides →
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 62993-0002-1 | 30 TABLET in 1 BOTTLE (62993-0002-1) | Oct 1, 2025 |
| 62993-0002-2 | 60 TABLET in 1 BOTTLE (62993-0002-2) | Oct 1, 2025 |
| 62993-0002-3 | 100 TABLET in 1 BOTTLE (62993-0002-3) | Oct 1, 2025 |
| 62993-0002-4 | 1000 TABLET in 1 BOTTLE (62993-0002-4) | Oct 1, 2025 |
| 62993-0002-5 | 3000 TABLET in 1 BOTTLE (62993-0002-5) | Oct 1, 2025 |
Other Docusate Sodium and Sennosides products
- 87717-502 Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Tablet · Morepen Bio Inc
- 35916-0453 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Capsule, Gelatin Coated · SOFTGEL HEALTHCARE PRIVATE LIMITED
- 35916-0454 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Capsule, Gelatin Coated · SOFTGEL HEALTHCARE PRIVATE LIMITED
- 35916-0477 Docusate Sodium 50 mg/1; Sennosides 8.6 mg/1 · Capsule, Liquid Filled · SOFTGEL HEALTHCARE PRIVATE LIMITED